London: A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barre syndrome (GBS), has been identified. Researchers at the University College London (UCL) said they are yet to understand the cause of the link. However, they noted that the small numbers […]
